Richard Godin/LinkedIn
Sep 15, 2026, 13:50
Richard Godin: Challenges in Diagnosing Homozygous Familial Hypercholesterolemia
Richard Godin, Global Medical Director at Regeneron, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Journal of Clinical Lipidology, adding:
”Clinicians face important challenges when considering diagnosing their patients with homozygous familial hypercholesterolemia.
My friends and I are happy to share our thoughts on the topic in a recent article published in the journal of clinical lipidology.”
Title: Exploring current challenges in diagnosing homozygous familial hypercholesterolemia: Insights from the historical evolution of diagnostic criteria
Authors: Daniel Gaudet, Richard Godin, Robert S. Rosenson, Gerald F. Watts
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 13, 2026, 03:21Abdul Muqtadir Abbasi: Iron Deficiency Beyond Anemia and the Importance of Finding the Cause
-
Nov 13, 2026, 03:05Marc Carrier: Aspirin vs Anticoagulants for VTE Prevention After Joint Replacement
-
Nov 13, 2026, 02:28Julia Sjöberg: ROCK1 Inhibition and Red Blood Cell Recovery After Chemotherapy
-
Nov 13, 2026, 02:07Tonie Reincke: Understanding Deep Vein Thrombosis and Vascular Health
-
Nov 13, 2026, 01:52Akshita Singh: The Remarkable Process of Blood Clotting
-
Nov 12, 2026, 22:52Milka Koupenova: The Role of Platelet RIG-I in Regulating Thrombotic Responses
-
Nov 12, 2026, 22:50Arun V J: Why Has India Still Not Achieved 100% Voluntary Blood Donation?
-
Nov 12, 2026, 22:49Sickle Cell Disease Deserves to Be Prioritised in Ghana – ISCC
-
Nov 12, 2026, 22:47Samir Kumar Beura: Delighted to Serve as a Topic Editor for a Research Topic in Frontiers in Neuroscience